Challenge of long-term benzodiazepine use in primary care: insights from a real-world cohort study in Catalonia

Introduction Long-term use of benzodiazepines (BZD) triggers health problems. Although Spain leads European use of BZD, the number of long-term users (LTUs) remains unknown.Objective The aim of the study is to estimate the proportion of primary care (PC) patients who initiate a BDZ prescription that...

Full description

Saved in:
Bibliographic Details
Main Authors: Marc Saez, Alexandra Lelia Dima, Blanca Lumbreras, Ignacio Aznar-Lou, María Teresa Peñarrubia-María, Antoni Serrano-Blanco, Lucy Anne Parker, Marta Puig-García, Marina Fuente-Moreno, Elsa Lopez-Pintor, Joan Domenech Abella, Adolfo Figueiras Guzmán, Elisa Chilet Rosell
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:Family Medicine and Community Health
Online Access:https://fmch.bmj.com/content/13/3/e003233.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849419687145766912
author Marc Saez
Alexandra Lelia Dima
Blanca Lumbreras
Ignacio Aznar-Lou
María Teresa Peñarrubia-María
Antoni Serrano-Blanco
Lucy Anne Parker
Marta Puig-García
Marina Fuente-Moreno
Elsa Lopez-Pintor
Joan Domenech Abella
Adolfo Figueiras Guzmán
Elisa Chilet Rosell
author_facet Marc Saez
Alexandra Lelia Dima
Blanca Lumbreras
Ignacio Aznar-Lou
María Teresa Peñarrubia-María
Antoni Serrano-Blanco
Lucy Anne Parker
Marta Puig-García
Marina Fuente-Moreno
Elsa Lopez-Pintor
Joan Domenech Abella
Adolfo Figueiras Guzmán
Elisa Chilet Rosell
author_sort Marc Saez
collection DOAJ
description Introduction Long-term use of benzodiazepines (BZD) triggers health problems. Although Spain leads European use of BZD, the number of long-term users (LTUs) remains unknown.Objective The aim of the study is to estimate the proportion of primary care (PC) patients who initiate a BDZ prescription that subsequently become LTU and to identify its associated factors.Design Retrospective real-world data cohort.Setting and participant It included the population over 15 years with a new prescription of BZD in PC in Catalonia. Users were considered LTU if they had been dispensed at least three prescriptions within 3 months. Sociodemographic characteristics of patients and prescribers, pathologies, previous BZD use, number and type of visits, and prescription quality standard were considered. We estimated the proportion of LTU among patients with a new prescription, stratified by age and sex, and estimated risk factors by multivariate generalised linear models.Result 100 638 users with a new BZD prescription were included. 27.1% were LTU at 3 months and 14.5% at 6 months. LTU increases with age and is higher in women. Predictors of LTU are Spanish nationality, living in rural areas, having a mental illness, having used BZD, having virtual visits or not meeting pharmacy-therapeutic quality standards.Conclusion The number of patients who develop LTU is high, especially in the elderly. Exploring the causes of this phenomenon could contribute to the development of future interventions.
format Article
id doaj-art-9ac2a8276ea744eaabcc7f812640ad2f
institution Kabale University
issn 2305-6983
2009-8774
language English
publishDate 2025-07-01
publisher BMJ Publishing Group
record_format Article
series Family Medicine and Community Health
spelling doaj-art-9ac2a8276ea744eaabcc7f812640ad2f2025-08-20T03:32:00ZengBMJ Publishing GroupFamily Medicine and Community Health2305-69832009-87742025-07-0113310.1136/fmch-2024-003233Challenge of long-term benzodiazepine use in primary care: insights from a real-world cohort study in CataloniaMarc Saez0Alexandra Lelia Dima1Blanca Lumbreras2Ignacio Aznar-Lou3María Teresa Peñarrubia-María4Antoni Serrano-Blanco5Lucy Anne Parker6Marta Puig-García7Marina Fuente-Moreno8Elsa Lopez-Pintor9Joan Domenech Abella10Adolfo Figueiras Guzmán11Elisa Chilet Rosell12Grupo de Investigación en Estadística, Econometría y Salud (GRECS), Univesitat de Girona, Girona, SpainConsorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, SpainDepartamento de Salud Pública, Historia de la Ciencia y Ginecología, Universidad Miguel Hernández, Alicante, SpainConsorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, SpainEAP Bartomeu Fabrés Anglada, Institut Català de la Salut, IDIAP Jordi Gol, Barcelona, Catalunya, SpainConsorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, SpainDepartamento de Salud Pública, Historia de la Ciencia y Ginecología, Universidad Miguel Hernández, Alicante, SpainDepartamento de Salud Pública, Historia de la Ciencia y Ginecología, Universidad Miguel Hernández, Alicante, SpainGrupo de Investigación en Evaluación de Tecnologías Sanitarias en Atención Primaria y Salud Mental (PRISMA), Institut de Recerca Sant Joan de Déu, Barcelona, SpainConsorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, SpainInstitut de Recerca Sant Joan de Déu, Barcelona, SpainDepartamento de Salud Pública, Universidad de Santiago de Compostela, Santiago de Compostela, SpainDepartamento de Salud Pública, Historia de la Ciencia y Ginecología, Universidad Miguel Hernández, Alicante, SpainIntroduction Long-term use of benzodiazepines (BZD) triggers health problems. Although Spain leads European use of BZD, the number of long-term users (LTUs) remains unknown.Objective The aim of the study is to estimate the proportion of primary care (PC) patients who initiate a BDZ prescription that subsequently become LTU and to identify its associated factors.Design Retrospective real-world data cohort.Setting and participant It included the population over 15 years with a new prescription of BZD in PC in Catalonia. Users were considered LTU if they had been dispensed at least three prescriptions within 3 months. Sociodemographic characteristics of patients and prescribers, pathologies, previous BZD use, number and type of visits, and prescription quality standard were considered. We estimated the proportion of LTU among patients with a new prescription, stratified by age and sex, and estimated risk factors by multivariate generalised linear models.Result 100 638 users with a new BZD prescription were included. 27.1% were LTU at 3 months and 14.5% at 6 months. LTU increases with age and is higher in women. Predictors of LTU are Spanish nationality, living in rural areas, having a mental illness, having used BZD, having virtual visits or not meeting pharmacy-therapeutic quality standards.Conclusion The number of patients who develop LTU is high, especially in the elderly. Exploring the causes of this phenomenon could contribute to the development of future interventions.https://fmch.bmj.com/content/13/3/e003233.full
spellingShingle Marc Saez
Alexandra Lelia Dima
Blanca Lumbreras
Ignacio Aznar-Lou
María Teresa Peñarrubia-María
Antoni Serrano-Blanco
Lucy Anne Parker
Marta Puig-García
Marina Fuente-Moreno
Elsa Lopez-Pintor
Joan Domenech Abella
Adolfo Figueiras Guzmán
Elisa Chilet Rosell
Challenge of long-term benzodiazepine use in primary care: insights from a real-world cohort study in Catalonia
Family Medicine and Community Health
title Challenge of long-term benzodiazepine use in primary care: insights from a real-world cohort study in Catalonia
title_full Challenge of long-term benzodiazepine use in primary care: insights from a real-world cohort study in Catalonia
title_fullStr Challenge of long-term benzodiazepine use in primary care: insights from a real-world cohort study in Catalonia
title_full_unstemmed Challenge of long-term benzodiazepine use in primary care: insights from a real-world cohort study in Catalonia
title_short Challenge of long-term benzodiazepine use in primary care: insights from a real-world cohort study in Catalonia
title_sort challenge of long term benzodiazepine use in primary care insights from a real world cohort study in catalonia
url https://fmch.bmj.com/content/13/3/e003233.full
work_keys_str_mv AT marcsaez challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia
AT alexandraleliadima challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia
AT blancalumbreras challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia
AT ignacioaznarlou challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia
AT mariateresapenarrubiamaria challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia
AT antoniserranoblanco challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia
AT lucyanneparker challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia
AT martapuiggarcia challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia
AT marinafuentemoreno challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia
AT elsalopezpintor challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia
AT joandomenechabella challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia
AT adolfofigueirasguzman challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia
AT elisachiletrosell challengeoflongtermbenzodiazepineuseinprimarycareinsightsfromarealworldcohortstudyincatalonia